Skip to content
10-Q

Quarterly Report

Orthofix Medical Inc. OFIX

0001193125-25-263670

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 39.6M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 39.47M sh
Shares Diluted Q3 2025 · Sep 30, 2024 38.49M sh
Shares Diluted Q3 2025 · Sep 30, 2024 37.94M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 $5.65M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $2.06M
Long Term Debt Q3 2025 · Sep 30, 2025 $157.22M
Long Term Debt Q3 2025 · Dec 31, 2024 $157.02M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $62.86M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $83.24M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $30.05M
Stockholders Equity Q3 2025 · Sep 30, 2025 $442.49M
Stockholders Equity Q3 2025 · Jun 30, 2025 $458.35M
Stockholders Equity Q3 2025 · Mar 31, 2025 $458.29M
Stockholders Equity Q3 2025 · Dec 31, 2024 $503.12M
Stockholders Equity Q3 2025 · Sep 30, 2024 $525.92M
Stockholders Equity Q3 2025 · Jun 30, 2024 $546M
Stockholders Equity Q3 2025 · Mar 31, 2024 $570.32M
Stockholders Equity Q3 2025 · Dec 31, 2023 $598.73M
Current Liabilities Q3 2025 · Sep 30, 2025 $159.85M
Current Liabilities Q3 2025 · Dec 31, 2024 $168.63M
Total Liabilities Q3 2025 · Sep 30, 2025 $390.12M
Total Liabilities Q3 2025 · Dec 31, 2024 $390.17M
Current Assets Q3 2025 · Sep 30, 2025 $394.17M
Current Assets Q3 2025 · Dec 31, 2024 $433.29M
Total Assets Q3 2025 · Sep 30, 2025 $832.61M
Total Assets Q3 2025 · Dec 31, 2024 $893.29M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.57
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.28
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.71
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.55
Eps Basic Q3 2025 · Sep 30, 2025 −$0.57
Eps Basic Q3 2025 · Sep 30, 2025 −$2.28
Eps Basic Q3 2025 · Sep 30, 2024 −$0.71
Eps Basic Q3 2025 · Sep 30, 2024 −$2.55
Sga Expense Q3 2025 · Sep 30, 2025 $148.1M
Sga Expense Q3 2025 · Sep 30, 2025 $417.58M
Sga Expense Q3 2025 · Sep 30, 2024 $130.14M
Sga Expense Q3 2025 · Sep 30, 2024 $396.05M
Rd Expense Q3 2025 · Sep 30, 2025 $14.77M
Rd Expense Q3 2025 · Sep 30, 2025 $50.47M
Rd Expense Q3 2025 · Sep 30, 2024 $17.29M
Rd Expense Q3 2025 · Sep 30, 2024 $54.84M
Net Income Q3 2025 · Sep 30, 2025 −$22.8M
Net Income Q3 2025 · Sep 30, 2025 −$89.97M
Net Income Q3 2025 · Jun 30, 2025 −$14.08M
Net Income Q3 2025 · Mar 31, 2025 −$53.09M
Net Income Q3 2025 · Sep 30, 2024 −$27.39M
Net Income Q3 2025 · Sep 30, 2024 −$96.85M
Net Income Q3 2025 · Jun 30, 2024 −$33.44M
Net Income Q3 2025 · Mar 31, 2024 −$36.02M
Operating Income Q3 2025 · Sep 30, 2025 −$17.05M
Operating Income Q3 2025 · Sep 30, 2025 −$81.92M
Operating Income Q3 2025 · Sep 30, 2024 −$18.9M
Operating Income Q3 2025 · Sep 30, 2024 −$73.14M
Gross Profit Q3 2025 · Sep 30, 2025 $148.52M
Gross Profit Q3 2025 · Sep 30, 2025 $409.68M
Gross Profit Q3 2025 · Sep 30, 2024 $135.05M
Gross Profit Q3 2025 · Sep 30, 2024 $397.04M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $57.11M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $192.73M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $61.55M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $186.79M
Revenue Q3 2025 · Sep 30, 2025 $205.63M
Revenue Q3 2025 · Sep 30, 2025 $602.4M
Revenue Q3 2025 · Sep 30, 2024 $196.61M
Revenue Q3 2025 · Sep 30, 2024 $583.83M